Utilizing endobronchial ultrasound with fine-needle aspiration to obtain tissue for molecular analysis a single-center experience

Journal of Bronchology and Interventional Pulmonology

Volumn 18, Issue 4, 2011, Pages 317-321

  Tanner, Nichole T ^a   Watson, Patricia ^b   Boylan, Alice ^a   Memoli, Jessica S Wang ^c   Pastis, Nicholas ^a   Taylor, Katherine ^a   Garrett Mayer, Elizabeth ^a   Silvestri, Gerard A ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b Dept of Medicine   (United States)

^c WASHINGTON HOSPITAL CENTER   (United States)

Author keywords

Endobronchial ultrasound; Lung cancer; Molecular analysis; Real time PCR

Indexed keywords

RNA;

ADULT; AGED; ARTICLE; ASPIRATION BIOPSY; CANCER DIAGNOSIS; CANCER PATIENT; CANCER STAGING; CONTROLLED STUDY; ENDOBRONCHIAL ULTRASONOGRAPHY; EPITHELIAL MESENCHYMAL TRANSITION; FEMALE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; LUNG CANCER; LYMPH NODE; MAJOR CLINICAL STUDY; MALE; MOLECULAR PROBE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION; RNA ISOLATION; TISSUE SECTION;

EID: 84856828047     PISSN: 19446586     EISSN: 19488270     Source Type: Journal    
DOI: 10.1097/LBR.0b013e3182341b07     Document Type: Article

References (13)

1. Parkin DM, Pisani P, Lopez AD, et al. Global cancer statistics, 2002. CA Cancer J Clin. 2005;55:74-108. (Pubitemid 40372904)
2. Molina JR, Adjei AA, Jett JR. Advances in chemotherapy of non-small cell lung cancer. Chest. 2006;130:1211-1219. (Pubitemid 44583755)
3. Annema, JT, van Meerbeeck JP, Rintoul RC, et al, Mediastinoscopy vs endosonography for mediastinal nodal staging of lung cancer: a randomized trial. JAMA. 2010;304(20):2245-2252.
4. Thiery JP, Acloque H, Huang RY, et al. Epithelialmesenchymal transitions in development and disease. Cell. 2009;139:871-890.
5. Yauch RL, Januario T, Eberhard DA, et al. Epithelial versus mesenchymal phenotype determines in vitro sensitivity and predicts clinical activity of erlotinib in lung cancer patients. Clin Cancer Res. 2005;11(24 Pt 1):8686-8698. (Pubitemid 43005918)
6. Nakajima T, Yasufuku K, Suzuki M, et al. Assessment of epidermal growth factor receptor mutation by endobronchial ultrasound-guided transbronchial needle aspiration. Chest. 2007;132:597-602. (Pubitemid 47282394)
7. Garcia-Olive I, Monso E, Andreo F, et al. Endobronchial ultrasound-guided transbronchial needle aspiration for identifying EGFR mutations. Eur Respir J. 2010;35:391-395.
8. Schuurbiers OC, Looijen-Salamon MG, Ligtenberg MJ, et al. A brief retrospective report on the feasibility of epidermal growth factor receptor and KRAS mutation analysis in transesophageal ultrasound- and endobronchial ultrasound-guided fine needle cytological aspirates. J Thorac Oncol. 2010;5:1664-1667.
9. van Eijk R, Licht J, Schrumpf M, et al. Rapid KRAS, EGFR, BRAF and PIK3CA mutation analysis of fine needle aspirates from non-small-cell lung cancer using allele-specific qPCR. PLoS One. 2011;6:e17791.
10. Sakairi Y, Nakajima T, Yasufuku K, et al. EML4-ALK fusion gene assessment using metastatic lymph node samples obtained by endobronchial ultrasoundguided transbronchial needle aspiration. Clin Cancer Res. 2011;16:4938-4945.
11. Billah S, Stewart J, Staerkel G, et al. EGFR and KRAS mutations in lung carcinoma: molecular testing by using cytology specimens. Cancer Cytopathol. 2011;119:111-117.
12. Nakajima T, Yasufuku K, Nakagawara A, et al. Multigene mutation analysis of metastatic lymph nodes in non-small celllung cancer diagnosed by EBUS-TBNA. Chest. 2011 Apr 28. [Epub ahead of print].
13. Mohamed S, Yasufuku K, Nakajima T, et al. Analysis of cell cycle-related proteins in mediastinal lymph nodes of patients with N2-NSCLC obtained by EBUS-TBNA: relevance to chemotherapy response. Thorax. 2008;63:642-647. (Pubitemid 351969259)